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Abstract: More than 500,000 U.S. women develop postpartum depression
(PPD) annually. Although psychosocial risks are known, the underlying biology
remains unclear. Dysregulation of the immune inflammatory response and the
hypothalamic–pituitary–adrenal (HPA) axis are associated with depression in
other populations. While significant research on the contribution of these
systems to the development of PPD has been conducted, results have been
inconclusive. This is partly because few studies have focused on whether
disruption in the bidirectional and dynamic interaction between the
inflammatory response and the HPA axis together influence PPD. In this
study, we tested the hypothesis that disruption in the inflammatory-HPA axis
bidirectional relationship would increase the risk of PPD. Plasma pro- and
anti-inflammatory cytokines were measured in women during the 3rd
trimester of pregnancy and on Days 7 and 14, and Months 1, 2, 3, and 6 after
childbirth. Saliva was collected 5 times the day preceding blood draws for
determination of cortisol area under the curve (AUC) and depressive
symptoms were measured using the Edinburgh Postpartum Depression
Survey (EPDS). Of the 152 women who completed the EPDS, 18% were
depressed according to EDPS criteria within the 6 months postpartum.
Cortisol AUC was higher in symptomatic women on Day 14 (p = .017). To
consider the combined effects of cytokines and cortisol on predicting
symptoms of PPD, a multiple logistic regression model was developed that
included predictors identified in bivariate analyses to have an effect on
depressive symptoms. Results indicated that family history of depression, day
14 cortisol AUC, and the day 14 IL8/IL10 ratio were significant predictors of
PPD symptoms. One unit increase each in the IL8/IL10 ratio and cortisol AUC
resulted in 1.50 (p = 0.06) and 2.16 (p = 0.02) fold increases respectively in
the development of PPD. Overall, this model correctly classified 84.2% of
individuals in their respective groups. Findings suggest that variability in the
complex interaction between the inflammatory response and the HPA axis
influence the risk of PPD.
Keywords: Postpartum depression, Inflammation, Cytokines, Cortisol,
Cytokine–cortisol feedback circuit, Psychoneuroimmune

1. Introduction
Postpartum depression (PPD) is a major mood disorder
(Association, 2013), affecting between 12% and 20% of new mothers
(Gavin et al., 2005 and Wisner et al., 2010). PPD is characterized by
persistent fatigue, sadness, and anxiety (Beck, 2006, Corwin et al.,
2005 and Hay et al., 2008) and carries significant and lifelong health
consequences for women and their infants (Field, 2010). These
consequences may be intergenerational, as infants born to mothers
with PPD grow up to be at an increased risk of developing a mood
disorder themselves (Hay et al., 2008 and Pearson et al., 2013).
Although psychosocial risk factors for PPD have long been considered,
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a growing appreciation of the mind–body connection in health and
disease has led to an increased focus on biological risk factors that
may underlie or contribute to the disorder. Two biological systems that
have come under investigation as potential contributors to PPD are the
immune-inflammatory response (Anderson and Maes, 2013, Boufidou
et al., 2009, Corwin et al., 2008, Groer and Morgan, 2007, Maes et al.,
2000, Okun et al., 2011 and Osborne and Monk, 2013) and the
hypothalamic–pituitary–adrenal (HPA) axis (Glynn et al., 2013,
O’Keane et al., 2011 and Okun et al., 2011). Both undergo significant
changes during pregnancy (Kalantaridou et al., 2010, Mastorakos and
Ilias, 2003 and Mor and Cardenas, 2010) and both remain in flux
during the early postpartum period (Christian and Porter, 2014,
Hebisch et al., 2004 and Mastorakos and Ilias, 2003).
While not an immunosuppressive state (Mor and Cardenas,
2010), for most of pregnancy there is a shift away from a proinflammatory and toward an anti-inflammatory milieu in the mother,
protecting the fetus from rejection (Aagaard-Tillery et al., 2006).
However, by the end of the 3rd trimester, a pro-inflammatory milieu
again emerges (Maes et al., 2000 and Mor and Cardenas, 2010),
playing an important role in the onset of parturition (Christiaens et al.,
2008). This pro-inflammatory response accelerates during labor, as
most women experience some degree of pain, anxiety, stress, and
fatigue during that time, each of which serves as a stimulus for the
secretion of pro-inflammatory cytokines (Steptoe et al.,
2007 and Watkins et al., 1999). The inflammatory response continues
into the postpartum period as both pro- and anti-inflammatory
mediators drive perineal healing and uterine involution as well as
mammary involution in women who chose to bottle feed (Chapwanya
et al., 2012, Hojilla et al., 2011, Nilsen-Hamilton et al.,
2003 and Salamonsen, 2003). Given the association between
inflammation and depression in non-pregnant, non-postpartum
populations (Dantzer and Kelley, 2007 and Raison and Miller, 2013),
more than a dozen research studies over the past two decades have
considered exaggerated postpartum inflammation as a risk factor for
PPD. A recent literature review, however, concluded that findings are
inconsistent and do not allow for conclusions or generalizations to be
made (Osborne and Monk, 2013). Limitations of prior studies include
small sample sizes, inclusion of women with birth complications,
limited reliability or validity of measures used to evaluate depression,
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and samples collected at a single time, or at inconsistent times, after
delivery. In addition, very few studies have addressed the biological
complexity of the psychoneuroimmune (PNI) response, specifically, the
bidirectional and dynamic interaction between the inflammatory
response and the HPA axis.
Like the immune system, the HPA axis is altered during
pregnancy; by the second trimester maternal levels of serum cortisol
are nearly double compared to levels seen in the non-pregnant state
(Mastorakos and Ilias, 2003). Key to this scenario is the increased
production of corticotropin-releasing hormone (CRH) by the placenta
and fetal membranes as pregnancy advances; the resultant increase in
cortisol production from these sources is resistant to negative
feedback, although suppression of maternal hypothalamic CRH in
response to the high levels of circulating cortisol is intact (Kalantaridou
et al., 2010). With delivery of the infant and expulsion of the placenta,
maternal cortisol levels fall significantly and quickly, to within the
upper normal range (Chrousos et al., 1998). Maternal postpartum CRH
suppression, however, has been hypothesized to continue for a
variable period of time (Kalantaridou et al., 2010, Mastorakos and
Ilias, 2003 and Vitoratos et al., 2006). A growing body of evidence
suggests that the abrupt fall in cortisol levels and postpartum HPA axis
suppression contribute to postpartum mood disorders (Bloch et al.,
2005, Chrousos et al., 1998, Glynn et al., 2013, Kalantaridou et al.,
2010, O’Keane et al., 2011 and Yim et al., 2009). Hyper- and hyposecretion of cortisol, and CRH deficiency have been linked to
depression in non-pregnant and non-postpartum individuals as well
(Charmandari et al., 2005, Chrousos, 1995 and Tsigos and Chrousos,
2002).
In addition to their individual effects, the pro-inflammatory
response and the HPA axis exhibit significant bidirectional interactions
via the well-documented cytokine–glucocorticoid feedback circuit
(Besedovsky and del Rey, 1996, Elenkov, 2008 and Elenkov et al.,
2005). In this circuit, an infectious or potentially injurious stressor
increases production of pro-inflammatory cytokines, which in turn
activate the HPA axis, increasing cortisol secretion. Rising cortisol
levels then bind to glucocorticoid receptors, including white blood cell
glucocorticoid receptors (Pace and Miller, 2009), ultimately turning off
further transcription of pro-inflammatory cytokines such as interleukinBrain, Behavior, and Immunity, Vol 49 (October 2015): pg. 86-93. DOI. This article is © Elsevier and permission has been
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10 (IL-10). The net effect of this feedback circuit is to alert the central
nervous system to the risk of an infectious or injurious stressor, while
at the same time limiting a potentially damaging or prolonged proinflammatory response and constraining further cortisol secretion. If
this circuit is disrupted, the ability of cortisol to limit inflammation may
be lost (Miller et al., 1999, Miller et al., 2002, Miller et al., 2008, Miller
et al., 2009 and Pace et al., 2012), leading to dysregulation of both
cytokine production and cortisol secretion (Corwin et al., 2013). Nearly
two decades ago, Chrousos and Tsigos suggested that disruption in the
HPA axis-immune system bidirectional relationship could increase
susceptibility to PPD (Chrousos, 1995 and Tsigos and Chrousos, 2002).
To our knowledge, this hypothesis has not yet been tested.

1.1. Research question
The inflammatory immune system and the HPA axis function in
a complex, inter-dependent manner over time to maintain baseline
and stress-related homeostasis. Abnormal inflammation or
dysregulation of the HPA axis has the potential to disrupt the
relationship, carrying adverse consequences for mental and physical
health. In light of the significant inflammatory and HPA axis changes
following labor and delivery, and the known associations between
depression, inflammation, and abnormal HPA axis activity in other
populations (Anisman and Merali, 2003 and Raison et al., 2006), we
tested the hypothesis that dysregulation in the bidirectional
relationship between inflammation and the HPA axis early in the
postpartum period would be associated with an increased risk of PPD
in otherwise healthy women.

2. Materials & methods
2.1. Procedure
Procedures were described in detail in a previous report
identifying a pattern of glucocorticoid resistance in the 3rd trimester of
pregnancy in the minority and low-income women enrolled in this
study (Corwin et al., 2013). Briefly, women who responded to ads
placed in community and clinic sites were recruited in their 2nd or
early 3rd trimester of pregnancy. Following a screening interview,
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those meeting inclusion criteria were visited at home by a registered
nurse a total of 7 times for data collection; once between 32 and
36 weeks of pregnancy and again at weeks one and two, and months
1, 2, 3, and 6 after delivery. At the prenatal home visit, participants
reviewed with the nurse the study protocol and provided informed
consent for their participation. Participants next completed a
demographic questionnaire providing information on age, marital
status, race/ethnicity, personal and family history of depression, and
whether or not they received government assistance through the
Women, Infants, and Children (WIC) assistance program. Self-report
of height, and pre-pregnancy weight was used for determination of
pre-pregnancy body mass index (BMI). At this visit and at all
subsequent home visits, women also completed questionnaires on
current health status and on the presence of depressive symptoms via
completion of the Edinburgh Postnatal Depression Scale (EPDS) (Cox
et al., 1987) and perceived stress. Any subject scoring high (⩾10) on
the EPDS or answered positively on the self-harm question were
interviewed by the nurse and the psychiatric provider for any needed
referrals or immediate intervention.
After completing all self-report tools, blood was drawn from the
antecubital vein into EDTA-containing tubes for later measurement of
plasma pro-inflammatory cytokines released as part of the innate
immune response and implicated in depression (Anisman and Merali,
2003 and Raison et al., 2006), including interleukin-6 (IL-6),
interleukin-1-beta (IL-1β), tumor necrosis factor-alpha (TNF-α),
interleukin-8 (IL-8) and interferon-gamma (IFN-γ). Because the
inflammatory response is regulated by the concurrent production of
anti-inflammatory cytokines, (Petrovsky, 2001), we also measured the
anti-inflammatory cytokine interleukin-10 (IL-10). In addition, during
the day prior to each home visit, subjects collected a saliva sample
upon awakening, 30-min after awakening, at 11:00 AM, 4:00 PM, and
8:00 PM. Home visits lasted approximately 30-min. At the end of each
home visit, women were compensated for participating and the next
home visit was arranged. All methods employed to improve the
accuracy and compliance of the home saliva collections (e.g., phone
calls prior to each sample collection, the use of Medication Event
Monitoring System [MEMS®], Aprex Corp., Fremont, Calif.)] caps, and
reimbursement for accurate collections have been described previously
(Corwin et al., 2013).
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2.2. Inclusion/exclusion criteria
Prenatal inclusion criteria were that all women were between 18
and 40 years of age, less than 36-weeks pregnant, non-smokers, and
anticipating the vaginal birth of a singleton infant. Additionally, women
were required to be without pregnancy restrictions, free of any known
chronic illness, and, with the exception of prenatal vitamins, not taking
any over-the-counter or prescribed medications or herbs including
anti-inflammatory or anti-depressant agents. Postnatal criteria for
continued inclusion were that women delivered a live infant via a
vaginal birth, without experiencing hemorrhage or transfusion, and
that both mother and infant left the hospital together within 72-h of
delivery. These inclusion/exclusion criteria were established to reduce
to the extent possible prenatal or postnatal conditions that might
themselves be associated with inflammation and/or depressed mood.
Subjects also were required to be without symptoms of infection at the
time of each home visit (or the visit was rescheduled) and to live
within a 20 miles of the laboratory, to minimize the time biological
samples were in transport. Postpartum visits at 1- and 2-weeks were
scheduled ±48-h, while the 1-, 2-, 3-, and 6-month visits were
scheduled ±1 week.

2.3. Measures
The 10-item EPDS was used for self-report of depressive
symptoms (Cox et al., 1987). It is an effective and easy to administer
screening tool that has been validated for both antepartum and
postpartum use. Answers to questions such as “I have looked forward
with enjoyment to things” are scored from 0 (“As much as I ever did”)
to 4 (“Hardly at all”). After completion, a woman’s score is summed to
provide information on the likelihood of clinical depression. Validation
of the EPDS against a diagnostic clinical interview identified a
specificity of 78%, a sensitivity of 86%, and a positive predictive value
of 73% for women scoring >10. Although a cut-point of >9 on the
EPDS during the first weeks postpartum has more recently been shown
to increase the specificity of the tool (Chaudron et al.,
2010 and Teissedre and Chabrol, 2004), we retained the traditional
cut-point since we were following participants through 6-months
postpartum where the cut-point recommendations are higher.
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The 14-item Perceived Stress Scale (PSS) was used to provide
information on participants’ perception of stress (Cohen et al., 1983).
The responses are based on a Likert-scale from 0 to 4, or from ‘‘never”
to ‘‘very often”. Each question asks the individual how she has been
feeling during the past month. The final score is a simple sum of each
item response, with some items reverse coded. In Cohen’s original
report, internal consistency reliability was high (Cronbach’s alpha
coefficients ranged from 0.84 to 0.86) as was test–retest correlation
(0.85). Evidence for concurrent and predictive validity was significant
at p < 0.05 (r = 0.49). Scores on the PSS have been shown to
correlate with measures of HPA axis function during pregnancy and the
post-partum period (Ruiz et al., 2003) and with depressive symptoms
(Shelton et al., 2014).

2.4. Biomarkers
Upon reaching the laboratory, blood samples were centrifuged
at 4 °C for 8 min at 2000 rpm. Plasma aliquots were placed into 1.5 cc
polypropylene microtubes and stored in the study lab at −80 °C, until
assayed using a Human Pro-inflammatory Ultra-Sensitive assay and
quantitative multiplex array technology (Meso Scale Discovery,
Gaithersburg, Maryland). All samples were measured in duplicate.
Intra-assay coefficient of variation was <5% and inter-assay
coefficient of variation was <10%. Cytokine concentrations are
reported individually and, since reciprocal interactions between proand anti-inflammatory cytokines finely tune the immune response
(Petrovsky and Harrison, 1997) and may best predict the risk for
depression in some clinical populations (Guilbaud et al.,
2009 and Taraz et al., 2012), the ratio of each pro-inflammatory
cytokine to anti-inflammatory cytokine (e.g., IL-6/IL-10) was
measured as well and considered in analyses.
Saliva samples were centrifuged at 4 °C for 3 min at 2000 rpm
after which they were aliquoted into 1.5 cc polypropylene microtubes
for storage at −80 °C until assayed using an expanded range high
sensitivity EIA kit (No. 1-3002/1-3012, Salimetrics, State College, PA).
Intra-assay coefficient of variation was 4.3% and inter-assay
coefficient of variation was 5.2%. The area under the curve (AUC) was
determined with respect to ground (Pruessner et al., 2003), and
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indicates the amount of cortisol secreted over the designated time
(μg/dL/hour).

2.5. Statistical analysis
For descriptive analysis of the study sample, mean (standard
deviations) and percentages were computed for continuous and
categorical demographics (such as age, race, marital status and
indicator of socioeconomic status) and baseline psychosocial variables
(prior history of depression, family history of depression, prenatal total
EPDS).
To compare differences in cytokine levels and their pro- to antiinflammatory ratios between groups of women who were symptomatic
of PPD (>10 on the EPDS) reported anytime up to 6 months
postpartum versus those not, independent sample Student t-tests
were performed. Because the cytokine and cortisol data were skewed,
natural log transformations were conducted prior to all analyses;
tables and graphs, however, report absolute levels. Temporal
differences in cytokine ratios (IL1β/IL10, IL6/IL10, IL8/IL10,
IFNγ/IL10, TNFα/IL10) and cortisol AUC in women non-symptomatic or
symptomatic of PPD were assessed at the prenatal visit and days 7
and 14, and months 1, 2, 3 and 6 postpartum using repeated
measures analysis. Graphical analysis was used to detect patterns in
cytokine ratios and cortisol AUC and their interactions and identify
time points where these were significantly different between women
non-symptomatic and symptomatic of depressive symptoms.
Consecutively, at time points that indicated significant differences,
joint cytokine–cortisol relationship trends were investigated for
groups- with and without symptoms of PPD by using multiple linear
regression methods and significant differences in trends were
graphically illustrated.
Because the outcome (whether symptomatic of PPD) is binary,
bivariate and multivariate logistic regressions were performed to
examine the individual (unadjusted) and joint (adjusted for other
predictors) effects of pro- to anti-inflammatory cytokine ratios, and
cortisol on the risk of PPD in postpartum women. Particularly, the proto anti-inflammatory cytokine ratios and cortisol AUCs at days 7 and
14 were evaluated to capture the dynamic, early postpartum milieu.
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The multiple logistic regression model adjusted for baseline
demographics and psychosocial characteristics that were significantly
different across the two groups. Cortisol, cytokines, and pro- to antiinflammatory cytokine ratios that were identified in the analyses to
have a theoretical or statistically significant effect on the occurrence of
depressive symptoms in postpartum women were included.
Statistical analysis was performed using SAS (version 9.2; SAS
Institute, Cary, NC) and SPSS 20. All statistical tests were two-sided
and a p value of <0.05 was considered statistically significant.

3. Results
3.1. Demographic data
Two-hundred and one women were enrolled in the study during
their 3rd trimester of pregnancy. Of this number, 49 (24%) were lost
or discontinued from further participation either prior to or
immediately following delivery due to the following reasons: lack of
interest or personal reasons (n = 8); having moved out of the area
(n = 2); ill infant unable to leave the hospital within 72-h of birth
(n = 5); stillbirth (n = 1); development of maternal prenatal health
complication (hypertension, n = 2); or labor and delivery complication
(cesarean birth, n = 26 or maternal hemorrhage/transfusion, n = 5).
This resulted in 152 women who continued in the study postpartum. Of
this group, 18% (n = 27) scored symptomatic of depression
(EPDS ⩾ 10) during the 6-months postpartum. Demographic and
psychosocial data for the entire group, and for those who did or did
not score symptomatic of depression, are shown in Table 1. Among
baseline demographic characteristics, self-report of prior history of
depression, prenatal EPDS score, and family history of depression
(p = 0.020, p = 0.033 and p = 0.008, respectively) were significantly
different in women who scored symptomatic of depression within 6months compared to those who did not and thus these variables were
controlled for in the final predictive model for PPD symptoms. PSS
scores were also significantly different between groups at every time
point; however, because they were also highly and positively
correlated (p < 0.0001) with our primary outcome variable (EPDS
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scores) across and between all-time points, we did not include PSS in
the final model.
Table 1. Demographic and clinical characteristics of women who were not or
were symptomatic of PPD (⩾10 on EPDS) at any time during the first 6months postpartum (mean ± SD).
Symptomatic of PPD in 1st 6 months
p-Value
No (n = 125)

Yes (n = 27)

Age

29.01(5.44)

28.70(4.29)

0.79

BMI

23.72(4.21)

24.48(4.58)

0.40

Marital status: married

80.0%

85.2%

0.51

Race: caucasian

76.0%

85.2%

0.30

Higher Income

72.6%

85.2%

0.17

Personal history of depression

18.4%

37.0%

0.03

Family history of depression

35.2%

63.0%

0.01

Prenatal EPDS
4.08(3.35)
6.64(4.60)
0.00
Percentages for marital status, race and SES do not add to 100% due to missing data.

3.2. Inflammatory markers
As shown in Table 2, levels of all cytokines were significantly
increased after delivery compared to prenatal levels, beginning by 1week postpartum and continuing, some throughout the study duration.
When comparing women who had a score indicating PPD to those who
were not depressed at any time, cytokine analyses at each time point
(days 7, 14, months 1, 2, 3 and 6) indicated that only TNFα levels
were significantly different between groups, with lower TNFα levels
(p < 0.05) at all time points in women symptomatic of PPD (Table 3).
There were no differences in any other cytokine or in the ratios of any
pro- to anti-inflammatory cytokine among women who did or did not
score symptomatic of depression, although day 14 IL-8/IL-10 ratio
was marginally higher among those symptomatic of PPD compared to
those non-symptomatic (p = 0.066). Repeated measures analysis
indicated that over time, the group symptomatic of depression had
lower TNF-α (p = 0.009), confirming findings from the cross-sectional
analysis. Similar trends in repeated measures analyses existed for all
other cytokines and pro- to anti-inflammatory cytokine ratios, i.e.,
lower individual cytokine levels but higher pro- to anti-inflammatory
ratios in women symptomatic of PPD.
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Table 2. Pro- and anti-inflammatory cytokine (pg/ml) levels (mean + SE)
and cortisol area under the curve (AUC) during the prenatal period through 6months postpartum.
Prenatal
IL-6

IFNγ

TNFα

IL-1β

IL-10

IL-8

Cortisol AUC

Day 7

Day 14 Month 1 Month 2 Month 3

Month 6

1.86

3.08∗∗

1.85

1.93

1.82

2.06∗

1.73∗

(±.20)

(±.28)

(±.19)

(±.21)

(±.28)

(±.49)

(±.18)

1.71

3.12∗∗

2.37∗∗

3.01∗∗

2.12∗∗

2.88∗∗

2.46∗∗

(±.16)

(±.49)

(±.27)

(±.38)

(±.20)

(±.58)

(±.36)

5.49

6.27∗∗

6.22∗∗

6.84∗∗

6.30∗∗

6.85∗∗

6.95∗

(±.29)

(±.37)

(±.34)

(±.37)

(±.35)

(±.42)

(±.52)

0.52

1.06∗∗

0.76∗∗

1.38∗∗

0.90∗

0.78∗

0.81∗

(±.07)

(±.39)

(±.13)

(±.49)

(±.21)

(±.14)

(±.18)

7.32

9.72∗∗

10.19∗

10.50

11.70

10.87

11.81

(±1.95)

(±2.96) (±4.13) (±3.21)

(±4.73)

(±3.66)

(±3.87)

4.10

6.02∗∗

6.52∗∗

5.99∗∗

5.94∗∗

5.69∗∗

5.66∗∗

(±.37)

(±.22)

(±.75)

(±.79)

(±1.08)

(±.76)

(±1.02)

3.29

2.35∗∗

1.96∗∗

1.68∗∗

1.72∗∗

1.60∗∗

1.64∗∗

(±.09)
(±.08) (±.07) (±.06)
(±.14)
For comparisons against prenatal levels: ∗ indicates p ⩽ 0.05,

∗∗

(±.05)
(±.09)
indicates p ⩽ 0.005.

Table 3. Pro- and anti-inflammatory cytokines (pg/ml) from day 7 through 6months postpartum in women who did or did not score symptomatic of PPD
(∗p < 0.05).
Day 7

Day 14

Month 1

Month 2

Month 3

Month 6

IL-6
EPDS < 10 3.13 ± .33 1.93 ± .23 2.03 ± .25 1.91 ± .34 2.21 ± .60 1.82 ± .22
EPDS > 10 2.45 ± .26 1.51 ± .20 1.47 ± .19 1.44 ± .21 1.12 ± .17 1.35 ± .18
IFNγ
EPDS < 10 3.38 ± .60 2.49 ± .33 3.21 ± .46 2.08 ± .20 3.01 ± 70

2.61 ± .44

EPDS > 10 2.00 ± .36 1.78 ± .24 1.83 ± .29 2.30 ± .64 1.86 ± .36 1.87 ± .31
TNF-α
EPDS < 10 6.65 ± .44∗ 6.57 ± .40∗ 7.22 ± .44∗ 6.65 ± .41∗ 7.31 ± .49∗ 7.50 ± .62∗
EPDS > 10 4.62 ± .50 4.68 ± .45 5.10 ± .53 4.81 ± .53 4.54 ± .47 4.64 ± .53
IL-1β
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Day 7

Day 14

Month 1

Month 2

Month 3

Month 6

EPDS < 10 1.15 ± .48 0.83 ± .16 1.38 ± .58 0.99 ± .25 0.79 ± .16 0.89 ± .23
EPDS > 10 0.68 ± .29 0.44 ± .07 1.31 ± .59 0.39 ± .08 0.47 ± .13 0.46 ± .16
IL-10
EPDS < 10 11.2 ± .3.7 11.8 ± 5.1 12.2 ± 3.9 13.6 ± 5.8 12.6 ± 4.5 13.9 ± 4.9
EPDS > 10 3.8 ± .0.8 3.6 ± 0.7

3.4 ± 0.6

3.8 ± 1.2

3.0 ± 0.5

3.3 ± 0.7

IL-8
EPDS < 10 6.05 ± .26 6.69 ± .93 6.34 ± .97 6.24 ± 1.33 5.91 ± .94 5.96 ± 1.26
EPDS > 10 6.09 ± .35 6.07 ± .42 4.61 ± .28 4.75 ± 0.26 4.61 ± .32 4.62 ± 0.44

3.3. Cortisol levels
Across the days of saliva collections, only during the early
postpartum period, on day 14, were cortisol levels higher in women
with PPD (p = 0.015) (Table 4). Cortisol AUC at day 14 was a
significant predictor of PPD symptoms and the odds of having PPD
symptoms increased by 82% with a one unit change in Cortisol AUC
(OR: 1.82, p = 0.025).
Table 4. Salivary cortisol Area Under the Curve (AUC) in women who were
not or were symptomatic of depression (EPDS ⩾ 10) at any time through 6months postpartum (mean ± SE).
Symptomatic of PPD in 1st 6 months
Time

p-Value
No (N = 125)

Yes (N = 27)

Prenatal

3.25(0.09)

3.65(0.27)

NS

Day 7

2.33(0.09)

2.51(0.22)

NS

Day 14

1.89(0.07)

2.36(0.20)

0.015∗

Month 1

1.65(0.06)

1.81(0.20)

NS

Month 2

1.58(0.05)

2.45(0.84)

NS

Month 3

1.61(0.06)

1.56(0.09)

NS

Month 6

1.66(0.12)

1.55(0.12)

NS

*p < 0.05.

3.4. Cytokine–cortisol interactions
The cytokines IL-6, IL-10, IL-8, and IFNγ tended to show
substantially different relationship patterns with cortisol AUC in women
who were symptomatic of depression compared to those nonsymptomatic, peaking at 2-weeks postpartum; these patterns were
significantly different for IL-6 and IL-10 (Fig. 1). Specifically, in the
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depressed women, cortisol AUC increased with increasing levels of
these cytokines; this was not true in the women without depression.
Instead, in the non-depressed women, there was no relationship
between any measured cytokine and cortisol AUC. These differences in
patterns between the two groups were more profound in the first
weeks after childbirth; any difference between groups disappeared
gradually after month 1. Lastly, because scrutiny of the cytokine data
identified some substantial outliers, we conducted a secondary
analysis of the data, deleting outliers as defined by inter-quartile range
(IQR) of cytokine ± three standard deviations. Since this did not
significantly impact our findings, and for the purpose of representing
all data, Fig. 1 is inclusive of all subjects.
Fig. 1. Interactions between natural log-transformed cytokine and cortisol
AUC in women who were and were not symptomatic of PPD at day 14.
Relationship between cortisol AUC and IL-6 and IL-10 were significantly
different (p = 0.007 and p = 0.004, respectively) for the two groups while
they were not significantly different for IL-8 and IFN-γ (p = 0.187 and
p = 0.274, respectively).
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To consider the combined effects of cytokines and cortisol on
predicting symptoms of PPD, a multiple logistic regression model was
developed that included predictors identified in bivariate analyses
(e.g., day 14 cortisol AUC, TNF-α, IL-8/IL-10 ratio, IL-6 and IL-10). In
addition, other baseline characteristics that were different across the
two groups were included and backward elimination was used to
identify the final model (Table 5). Neither baseline EPDS scores,
personal history of depression, nor TNF-α, IL-6, IL-10 or their ratios
(TNF-α/IL-10, IL6/IL10) were significant in predicting PPD symptoms
in postpartum women and were discarded from the final model.
Table 5. Estimates of effects (odds ratios) from multiple logistic regression
model for predicting PPD symptoms.
95% C.I. for EXP(B)
Predictors

B

S.E.

Sig. Exp(B)
Lower

Upper

Depression_famhx(1)

−1.217 0.546 .026 .296

.101

.864

Day14_IL8_IL10_PCytokine_log

.406

0.216 .060 1.50

0.984

2.292

Day14_AUC

0.770

0.334 .021 2.160

1.123

4.156

Constant

−2.867 0.782 .000 .057

As shown in Table 5, the final multiple logistic regression model
indicated that family history of depression, day 14 IL8/IL10 ratio and
day 14 cortisol AUC were statistically significant predictors of PPD
symptoms. Particularly, a unit increase in the IL8/IL10 ratio and a unit
(1 h) increase in the cortisol AUC resulted in a 1.50 (p = 0.06) and
2.16 (p = 0.02) times increase in the likelihood of observing
depressive symptoms in postpartum women respectively. In contrast,
not having a prior family history of depression resulted in a 45.4%
(p = 0.03) decrease in observing depressive symptoms. Overall, this
model correctly classified 84.2% of the participants. Even without
including a family history of depression, the model correctly classified
82.5% of individuals.

4. Conclusions
Although significant research has been conducted to identify and
relieve psychosocial risk factors for PPD (Dennis and Dowswell, 2013),
considering psychosocial risk factors alone continues to leave a large
amount of variance in risk of PPD unexplained. A growing appreciation
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of the mind–body connection in health and disease has led to an
increased focus on biological processes that may underlie or contribute
to the disorder (Albacar et al., 2010, Binder et al., 2010, Bloch et al.,
2000, Corwin et al., 2003, Costas et al., 2010, Figueira et al., 2010,
Goshtasebi et al., 2013, Guintivano et al., 2013, Kimmel et al., 2013,
Le Donne et al., 2012, Maes et al., 2002 and O’Keane et al., 2011). In
the current study, our primary finding, that variability in the
functioning of the bi-directional interactions between the immuneinflammatory response and the HPA axis within the first weeks after
childbirth influences a woman’s risk of PPD, further emphasizes the
importance of an integrated PNI response in the postpartum mental
health continuum.
Although our original hypothesis was that dysregulation of the
cytokine/cortisol relationship postpartum would increase a woman’s
risk of PPD, our data suggest just the opposite: “dysregulation” after
giving birth may protect women against depressed mood. This paradox
of high cytokines and low cortisol provides additional support for the
recognition of pregnancy and the postpartum as physiologically unique
periods of life characterized by tightly regulated inflammatory states
(Aagaard-Tillery et al., 2006 and Mor and Cardenas, 2010; Shelton et
al., 2014).
The changes in cytokine and cortisol AUC levels after delivery
compared to levels during the 3rd trimester of pregnancy (Table 2)
highlight the significant activation of both arms of the immune
response in the first days and weeks after childbirth. In nonpostpartum individuals, sudden increases in pro-inflammatory
cytokines similar to those seen immediately after childbirth might be
expected to increase cortisol secretion (Besedovsky and del Rey,
2006). However, our data suggest that in healthy women, this
response is blunted or absent; thus although pro-inflammatory
cytokines rise following labor and delivery, cortisol levels do not,
reflecting postpartum HPA axis suppression continuing for at least the
first 2-weeks after delivery. In contrast, for women who develop
symptoms of PPD, the cytokine stimulation of cortisol secretion in the
early postpartum is robust, and negatively impacts mood. We propose
that these women experience an early postpartum return of
hypothalamic responsiveness, as suggested by the significantly
positive interactive effect between cytokines and cortisol in postpartum
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women who developed significant symptoms of PPD but not in women
who did not (Fig. 1).
The data presented in Table 2, showing mean cytokine and
cortisol AUC levels from the 3rd trimester of pregnancy through 6months postpartum are also notable in that they provide for the first
time, a comprehensive view of PNI activity across approximately 8months during this critical pre- to post-natal period (32–36 weeks of
pregnancy – 6 months postpartum). The significant changes in both
the innate immune response and the HPA axis during pregnancy and
the postpartum period highlight the uniqueness of these times in a
woman’s life (Aagaard-Tillery et al., 2006 and Mor and Cardenas,
2010). Further investigation of these cytokine profiles over time in a
larger sample is warranted.
Although research supporting a direct, positive association
between markers of inflammation and major depression has been
identified in a variety of populations, evidence for this linkage in
pregnant and postpartum women has been inconclusive (Osborne and
Monk, 2013). In this study, we found that decreased levels of TNF-α
were associated with symptoms of depression, although when
considering the ratio of TNF-α/IL-10, this relationship was lost.
Deceased TNF-α in the depressed women, might also reflect an intact
cytokine-glucocorticoid feedback circuit in this population, where
higher levels of cortisol limit further secretion of pro-inflammatory
cytokines (Pace et al., 2012 and Yang and Glaser, 2002). The
cytokine-glucocorticoid feedback circuit appears not to be active in
women who do not develop symptoms of PPD, further suggesting that
cytokine/cortisol “dysregulation” may be beneficial during this unique
time.
The data presented in this also study may partially explain why
previous studies of the relationship between cytokines and the
development of PPD have been inconclusive, and why both hyper- and
hypo-activity of the HPA axis have been linked with risk of PPD. First,
our data suggest that cytokines and cortisol interact to influence
mood, and that the timing and sequence of their interactions during
the postpartum period is critical. In addition, considering the balance
of pro- to anti-inflammatory cytokines, rather than just individual
cytokines, appears necessary to uncover the full picture. While proBrain, Behavior, and Immunity, Vol 49 (October 2015): pg. 86-93. DOI. This article is © Elsevier and permission has been
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inflammatory cytokines, such as TNF-α, IFN-γ, IL-1β, and IL-6
coordinate the non-specific (inflammatory) immune responses, antiinflammatory cytokines such as interleukin IL-10 not only provide
negative feedback to limit inflammation, but also support development
of a type 2, or specific immune response (Petrovsky and Harrison,
1997). The findings in this study emphasize the importance of the
interplay between these two arms of the immune response to affect
mood, and mirror findings from other studies emphasizing the
importance of considering pro- to anti-inflammatory cytokine ratios
when evaluating risks for depression (Bensimon et al.,
2014 and Fredericks et al., 2010). And lastly, the variability in
previously published findings on inflammation and PPD may be due as
well to the timing of sample collections, the sources of sample, or the
inclusion of women with confounding perinatal experiences such as
surgical birth or transfusion, or co-morbidities known to affect the
immune system or mood.
Limitations to this study include a relatively small number of
participants and reliance on self-report of key variables including prepregnancy body weight and height, affective symptoms, and personal
and family history of depression. The inclusion of self-report of
personal and family history of depression may be especially
problematic since we did not require that answering “yes” to either
required that they be confirmed by a clinical diagnosis and/or treated
medically, although some women might have interpreted the question
that way. Likewise, requiring that all postpartum women must have
had an uncomplicated, vaginal delivery of a healthy singleton infant,
and that both mother and infant left the hospital together within 72-h
of delivery, limits the generalizability of our findings. Lastly, this study
utilized only indirect evidence of postpartum HPA axis responsiveness.
Clearly, further investigation of the hypotheses tested in this study is
needed in order to better understand the underlying mechanisms of
PPD and to predict and prevent its occurrence in susceptible women.
In summary, to our knowledge, our study provides the first
evidence that HPA axis responsiveness to inflammatory mediators in
the early weeks after delivery significantly increases the risk of PPD.
By simultaneously collecting and analyzing longitudinal data on
cytokines and HPA activity we were able to detect an interaction
between these two systems. It appears that variability in HPA axis
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responsiveness during the postpartum period may explain why some
women develop depression when exposed to the inflammatory stimuli
associated with the childbearing process while others do not.
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